BEN vs CDTX · P/E 36, rev $8.77B vs rev $1.3M
Franklin Resources Inc (BEN) versus Cidara Therapeutics Inc (CDTX) — a side-by-side from cached financials, not a winner call.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
BEN currently screens at market cap $13.09B and trailing P/E 35.6. CDTX currently screens at market cap $6.96B.
Not investment advice. Open the BEN and CDTX stock pages for the full models.
Not investment advice.